NeurologyLive Peer Exchange

The NeurologyLive® Peer Exchange video series features panels of expert physicians engaging in in-depth discussions about practice-changing treatments, challenges in care, and the future paradigm of management for neurologic diseases.

4 KOLs are featured in this series

Treatment Advances in Targeting Underlying Pathophysiology of Myasthenia Gravis

October 25th 2024
Therapeutic Options and Clinical Considerations in the Management of Spasticity

Therapeutic Options and Clinical Considerations in the Management of Spasticity

June 16th 2024
Treatment and Management of Mild-to-Moderate Multiple Sclerosis

Treatment and Management of Mild-to-Moderate Multiple Sclerosis

June 12th 2024
5 KOLs in this panel

Managing Spinal Muscular Atrophy in Adult Patients

June 10th 2024
Preparing for a New Era in Alzheimer's Disease: Debating New Targeted Biomarkers and Therapeutic Approaches

Preparing for a New Era in Alzheimer's Disease: Debating New Targeted Biomarkers and Therapeutic Approaches

May 6th 2024
Effective Management of Excessive Daytime Sleepiness and Narcolepsy

Effective Management of Excessive Daytime Sleepiness and Narcolepsy

March 29th 2024
Optimizing Outcomes in Myasthenia Gravis Through Personalized Care and Treatment Selection

Optimizing Outcomes in Myasthenia Gravis Through Personalized Care and Treatment Selection

March 26th 2024
Anti-CD20 Monoclonal Antibodies and Future Directions in Multiple Sclerosis Care

Anti-CD20 Monoclonal Antibodies and Future Directions in Multiple Sclerosis Care

March 25th 2024
CMSC Consensus Panel Guidance on the Use of Serum Neurofilament Light Chain in the Management of Multiple Sclerosis

CMSC Consensus Panel Guidance on the Use of Serum Neurofilament Light Chain in the Management of Multiple Sclerosis

January 15th 2024

Dual-Orexin Receptor Antagonists for Treatment of Insomnia

December 21st 2023
Novel Mechanisms of Action in Multiple Sclerosis: Focus on BTK Inhibitors

Novel Mechanisms of Action in Multiple Sclerosis: Focus on BTK Inhibitors

November 6th 2023
How Similar Are Biosimilars? A Look Into the Future With Biosimilars in Multiple Sclerosis

How Similar Are Biosimilars? A Look Into the Future With Biosimilars in Multiple Sclerosis

June 27th 2023
The Shifting Treatment Landscape of RRMS

The Shifting Treatment Landscape of RRMS

April 26th 2023
Management of Dyskinesia and Advances in Treatment of Parkinson's Disease

Management of Dyskinesia and Advances in Treatment of Parkinson's Disease

March 28th 2023
Updates in the Management of Neuromyelitis Optica Spectrum Disorder Care (NMOSD)

Updates in the Management of Neuromyelitis Optica Spectrum Disorder Care (NMOSD)

March 22nd 2023
Advances in the Management of Excessive Daytime Sleepiness and Narcolepsy

Advances in the Management of Excessive Daytime Sleepiness and Narcolepsy

March 17th 2023
Expert Perspectives on Recent Advances in Alzheimer’s Disease

Expert Perspectives on Recent Advances in Alzheimer’s Disease

December 22nd 2022
Improving Outcomes in Spinal Muscular Atrophy Through Early Identification and Personalization of Care / Melhorando resultados em Atrofia Muscular Espinhal (AME) através da identificação precoce e cuidado personalizado

Improving Outcomes in Spinal Muscular Atrophy Through Early Identification and Personalization of Care / Melhorando resultados em Atrofia Muscular Espinhal (AME) através da identificação precoce e cuidado personalizado

December 14th 2022
Challenges and Solutions in the Management of Multiple Sclerosis

Challenges and Solutions in the Management of Multiple Sclerosis

November 22nd 2022
Sleep Disorders and Health Conditions: Focus on Insomnia

Sleep Disorders and Health Conditions: Focus on Insomnia

October 12th 2022
Neuromyelitis Optica Spectrum Disorder (NMOSD) Care in Diverse Patient Populations

Neuromyelitis Optica Spectrum Disorder (NMOSD) Care in Diverse Patient Populations

September 2nd 2022
Demystifying Multiple Sclerosis Etiology: Molecular Mimicry and The Role of Epstein-Barr Virus

Demystifying Multiple Sclerosis Etiology: Molecular Mimicry and The Role of Epstein-Barr Virus

June 30th 2022
Cognitive Health and Sphingosine-1-Phospate Receptor Modulators in Multiple Sclerosis

Cognitive Health and Sphingosine-1-Phospate Receptor Modulators in Multiple Sclerosis

June 29th 2022
Immune Response in the Management of MS

Immune Response in the Management of MS

May 6th 2022
Considerations for the Maintenance of ON Time in Parkinson Disease

Considerations for the Maintenance of ON Time in Parkinson Disease

May 5th 2022
Demystifying Multiple Sclerosis Etiology: The Role of Epstein-Barr Virus

Demystifying Multiple Sclerosis Etiology: The Role of Epstein-Barr Virus

March 18th 2022
Optimal Management of Acute and Preventive Migraine

Optimal Management of Acute and Preventive Migraine

January 18th 2022
Experts on Insomnia

Unmet Needs in Treating Insomnia

December 20th 2021
The Changing Landscape of Preventive Treatment of Migraine

The Changing Landscape of Preventive Treatment of Migraine

November 19th 2021
Parkinson’s Disease On-Demand Morning Therapy

Parkinson’s Disease On-Demand Morning Therapy

October 12th 2021
12>
© 2024 MJH Life Sciences

All rights reserved.